Christopher Hino Kevin Nishino Bryan Pham Won Jin Jeon Michael Nguyen Huynh Cao
10.3389/fimmu.2022.993622
Front Immunol
2022 Aug 16;13:993622.
sarcomatoid renal cell carcinoma (srcc) acute interstitial nephritis (ain) adrenal insufficiency hypothyroidism, diabetes mellitus immune related adverse events ipilimumab (pubchem sid
CC BY
https://pubmed.ncbi.nlm.nih.gov/36052087/
Carcinoma, Renal Cell Kidney Neoplasms Nephritis, Interstitial / chemically induced Nephritis, Interstitial / diagnosis
Carcinoma, Renal Cell Kidney Neoplasms Nephritis, Interstitial / chemically induced Nephritis, Interstitial / diagnosis Case Reports Review Antineoplastic Combined Chemotherapy Protocols / adverse effects Humans Ipilimumab / adverse effects Male Middle Aged Nivolumab / therapeutic use Ipilimumab Nivolumab Acute Tubulointerstitial Nephritis
PMC9425087
36052087
Nivolumab plus ipilimumab induced endocrinopathy and acute interstitial nephritis in metastatic sarcomatoid renal-cell carcinoma: A case report and review of literature
2022